Home | Prescription Drugs | Omnaris

Omnaris (Ciclesonide)

Type
Drug
Manufacturer
Country
Dosage
Qty
Price(USD)
Type:
Drug:Omnaris Nasal Spray
ManufacturerCovis Pharma
Country:Canada
Dosage:50 mcg/120 dose
Qty:1
Price:$57.99
Type:
Drug:Omnaris Nasal Spray
ManufacturerTakeda
Country:Australia
Dosage:50 mcg/120 dose
Qty:1
Price:$87.99
Type:
Drug:Omnaris Nasal Spray
ManufacturerTakeda
Country:Australia
Dosage:50 mcg/120 dose
Qty:2
Price:$157.99
Type:
Drug:Omnaris Nasal Spray
ManufacturerCovis Pharma
Country:Canada
Dosage:50 mcg/120 dose
Qty:2
Price:$107.99
Type:
Drug:Omnaris Nasal Spray
ManufacturerCovis Pharma
Country:Canada
Dosage:50 mcg/120 dose
Qty:3
Price:$147.99
Type:
Drug:Omnaris Nasal Spray
ManufacturerTakeda
Country:Australia
Dosage:50 mcg/120 dose
Qty:3
Price:$207.99
Medically Reviewed By: Dr. Bolanle Aina, Pharmacist on 11/8/2023 9:41:00 AM.

Omnaris is a corticosteroid and is used in adults and adolescents 12 years of age or older, to relieve the symptoms that may occur with hay fever (seasonal allergic rhinitis or perennial allergic rhinitis, including stuffiness, congestion in the nose, runny nose, itching, and sneezing. This medication is used in the nose. When taken as per directions, it reduces the inflammation in the lining of the nose and nasal passages. Its therapeutic effects may not be immediate. It may take a few days for this medicine to work. It is very important to use Omnaris regularly. Do not stop treatment even if you feel better unless told by the doctor. Your doctor will decide what an appropriate dosage of Omnaris is for you. The recommended dosage is 2 sprays in each nostril once daily (total daily dose, 200 mg). The maximum total daily dosage should not exceed 2 sprays in each nostril (200 mg/day).

Manufacturer Information

Omnaris is available from Canada by AstraZeneca and Australia by Takeda. The active ingredient in Omnaris is ciclesonide. Omnaris is available as a nasal spray. It comes in a bottle with a manual metered pump. Each spray activation delivers 50 mg/120 dose of Omnaris in a metered dose.

Stop taking Omnaris and call your doctor at once if you have one of these serious side effects:

• Allergic reaction
• Fungal infection in nose

Less serious side effects include headache, nose bleeds, nasal ulcers, pain, burning irritation, or dryness inside the nose, nausea, dry mouth, decreased taste sensitivity, and sore throat. Please call your doctor if you have any further concerns or questions.

Do not take Omnaris if you have or had allergy to ciclesonide or any other ingredients in the medication, have untreated infection in the nose, your nose was recently operated or injured. Omnaris should not be used in children under 2 years of age. Before taking Omnaris, inform your doctor if you have liver disease, are pregnant or breastfeeding. Omnaris should not be used in children or adolescents less than 18 years of age. Omnaris can interact with ketoconazole, itraconazole, ritonavir, or nelfinavir.

The content on this page has been supplied to canadianpharmacyking by an independent third party contracted to provide information for our website. canadianpharmacyking relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional. Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, New Zealand, Australia, Turkey, Mauritius, India, and the United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with licensed pharmacies and fulfillment centers that procure products from reliable sources.